Estrogen as Neuroprotectant of Nigrostriatal Dopaminergic System: Laboratory and Clinical Studies

Author： Dluzen Dean E. Horstink Martin W. I. M.

ISSN： 0969-711X

Source： Endocrine Journal, Vol.21, Iss.1, 2003-06, pp. : 67-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Targeting of Estrogen Receptor Signaling in the Cardiovascular System: Preclinical and Clinical Studies

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 2, 2004-04 ,pp. : 107-122

Bentham Science Publishers

Access to resources Recommend Favorite

Estrogen receptor- and the cardiovascular system

By Levin E.R.

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 5, 2002-07 ,pp. : 184-185

Elsevier

Access to resources Recommend Favorite

Estrogen, aging and the cardiovascular system

By Stice James P Lee Jennifer S Pechenino Angela S Knowlton Anne A

Future Cardiology, Vol. 5, Iss. 1, 2009-01 ,pp. : 93-103

Future Medicine

Access to resources Recommend Favorite

Effects of Thyroid Hormone on the Renal Dopaminergic System

By Del Compare J.A. Aguirre J.A. Ibarra F.R. Barontini M. Armando I.

Endocrine Journal, Vol. 15, Iss. 3, 2001-08 ,pp. : 297-303

Humana Press, Inc

Access to resources Recommend Favorite

Changes in estrogen receptor-α expression in hypothalamic dopaminergic neurons during proestrous prolactin surge

By Hou Yueping Yang Shu-Ping Voogt James

Endocrine Journal, Vol. 20, Iss. 1-2, 2003-02 ,pp. : 131-138

Humana Press, Inc

Access to resources Recommend Favorite